TY - JOUR
T1 - Multisite Dopamine Sensing With Femtomolar Resolution Using a CMOS Enabled Aptasensor Chip
AU - Sessi, Violetta
AU - Ibarlucea, Bergoi
AU - Seichepine, Florent
AU - Klinghammer, Stephanie
AU - Ibrahim, Imad
AU - Heinzig, André
AU - Szabo, Nadine
AU - Mikolajick, Thomas
AU - Hierlemann, Andreas
AU - Frey, Urs
AU - Weber, Walter M.
AU - Baraban, Larysa
AU - Cuniberti, Gianaurelio
N1 - Publisher Copyright:
Copyright © 2022 Sessi, Ibarlucea, Seichepine, Klinghammer, Ibrahim, Heinzig, Szabo, Mikolajick, Hierlemann, Frey, Weber, Baraban and Cuniberti.
PY - 2022/6/3
Y1 - 2022/6/3
N2 - Many biomarkers including neurotransmitters are found in external body fluids, such as sweat or saliva, but at lower titration levels than they are present in blood. Efficient detection of such biomarkers thus requires, on the one hand, to use techniques offering high sensitivity, and, on the other hand, to use a miniaturized format to carry out diagnostics in a minimally invasive way. Here, we present the hybrid integration of bottom-up silicon-nanowire Schottky-junction FETs (SiNW SJ-FETs) with complementary-metal–oxide–semiconductor (CMOS) readout and amplification electronics to establish a robust biosensing platform with 32 × 32 aptasensor measurement sites at a 100 μm pitch. The applied hetero-junctions yield a selective biomolecular detection down to femtomolar concentrations. Selective and multi-site detection of dopamine is demonstrated at an outstanding sensitivity of ∼1 V/fM. The integrated platform offers great potential for detecting biomarkers at high dilution levels and could be applied, for example, to diagnosing neurodegenerative diseases or monitoring therapy progress based on patient samples, such as tear liquid, saliva, or eccrine sweat.
AB - Many biomarkers including neurotransmitters are found in external body fluids, such as sweat or saliva, but at lower titration levels than they are present in blood. Efficient detection of such biomarkers thus requires, on the one hand, to use techniques offering high sensitivity, and, on the other hand, to use a miniaturized format to carry out diagnostics in a minimally invasive way. Here, we present the hybrid integration of bottom-up silicon-nanowire Schottky-junction FETs (SiNW SJ-FETs) with complementary-metal–oxide–semiconductor (CMOS) readout and amplification electronics to establish a robust biosensing platform with 32 × 32 aptasensor measurement sites at a 100 μm pitch. The applied hetero-junctions yield a selective biomolecular detection down to femtomolar concentrations. Selective and multi-site detection of dopamine is demonstrated at an outstanding sensitivity of ∼1 V/fM. The integrated platform offers great potential for detecting biomarkers at high dilution levels and could be applied, for example, to diagnosing neurodegenerative diseases or monitoring therapy progress based on patient samples, such as tear liquid, saliva, or eccrine sweat.
KW - CMOS (complementary metal oxide semiconductor)
KW - aptasensor
KW - dopamine detection
KW - multisite array
KW - silicon nanowire
UR - https://www.scopus.com/pages/publications/85133388727
U2 - 10.3389/fnins.2022.875656
DO - 10.3389/fnins.2022.875656
M3 - Article
AN - SCOPUS:85133388727
SN - 1662-4548
VL - 16
JO - Frontiers in Neuroscience
JF - Frontiers in Neuroscience
M1 - 875656
ER -